Change Healthcare Inc. (NASDAQ: CHNG) is 27.18% higher on its value in year-to-date trading and has touched a low of $6.18 and a high of $19.08 in the current 52-week trading range. The CHNG stock was last observed hovering at around $18.24 in the last trading session, with the day’s gains setting it 5.48% off its average median price target of $22.00 for the next 12 months. It is also 8.77% off the consensus price target high of $26.00 offered by 19 analysts, but current levels are -31.78% lower than the price target low of $18.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $23.72, the stock is 29.85% and 39.49% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 86.72 million and changing 30.04% at the moment leaves the stock 77.16% off its SMA200. CHNG registered 51.57% gain for a year compared to 6-month gain of 126.55%. The firm has a 50-day simple moving average (SMA 50) of $17.84 and a 200-day simple moving average (SMA200) of $14.47.
The stock witnessed a 33.11% loss in the last 1 month and extending the period to 3 months gives it a 59.95%, and is 30.54% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.37% over the week and 3.00% over the month.
Change Healthcare Inc. (CHNG) has around 15000 employees, a market worth around $7.19B and $3.10B in sales. Fwd P/E is 14.52. Profit margin for the company is -5.80%. Distance from 52-week low is 283.82% and 24.32% from its 52-week high. The company has generated returns on investments over the last 12 months (3.20%).
Change Healthcare Inc. (CHNG) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Change Healthcare Inc. (CHNG) is a “Overweight”. 19 analysts offering their recommendations for the stock have an average rating of 1.60, where 7 rate it as a Hold and 0 think it is a “Overweight”. 12 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Change Healthcare Inc. quarterly earnings per share for the current quarter are estimated at $0.31 with sales reaching $783.77M over the same period.The EPS is expected to shrink by -101.30% this year, but quarterly earnings will post -7.20% year-over-year.
Change Healthcare Inc. (CHNG) Top Institutional Holders
333 institutions hold shares in Change Healthcare Inc. (CHNG), with 1.06M shares held by insiders accounting for 0.35% while institutional investors hold 102.62% of the company’s shares. The shares outstanding are 320.64M, and float is at 303.39M with Short Float at 4.03%. Institutions hold 102.27% of the Float.
The top institutional shareholder in the company is Blackstone Group Inc. with over 59.62 million shares valued at $865.09 million. The investor’s holdings represent 19.58% of the CHNG Shares outstanding. As of Sep 29, 2020, the second largest holder is Vanguard Group, Inc. (The) with 19.48 million shares valued at $282.71 million to account for 6.40% of the shares outstanding. The other top investors are Clarkston Capital Partners LLC which holds 18.61 million shares representing 6.11% and valued at over $270.04 million, while Boston Partners holds 4.93% of the shares totaling 15.02 million with a market value of $217.95 million.
Change Healthcare Inc. (CHNG) Insider Activity
The most recent transaction is an insider purchase by Eliasson Fredrik J, the company’s EVP & CFO. SEC filings show that Eliasson Fredrik J bought 100,000 shares of the company’s common stock on Jun 10 at a price of $12.00 per share for a total of $1.2 million. Following the purchase, the insider now owns 0.14 million shares.